Hypertension, chronic kidney disease, and NAFLD/NASH are frequently first diagnosed in primary care. Try these 10 questions on diagnosis and treatment of all 3.
Hypertension, chronic kidney disease, and NAFLD/NASH are linked by numerous underlying metabolic pathways and often seen together in primary care patients.
As part of our cardiometabolic disease clinical topic area, this set of questions draws on several previous Patient Care quizzes you may have taken. Consider this one a review. Good luck.
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
October 14th 2024Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.